10/10/2014

Protecting Your Skin

…later develop into melanoma and other skin cancers. Sun protection is essential to melanoma prevention because exposure to ultraviolet (UV)…
10/14/2014

Mole Mapping

…history of melanoma in your family? Have you been diagnosed with melanoma? Do you have any large moles (diameter more…
11/12/2014

Terms of Use

…names, trademarks and service marks of the Foundation include without limitation, “AIM at Melanoma,” “Melanoma 360,” “International Melanoma Working Group,”…
01/26/2021

Monthly Giving Program

…Melanoma Working Group, a global collaboration of 25+ of the world’s leading experts in melanoma, who are determined to advance…
08/17/2022

UC Cancer Center | September 24, 2022

…This presentation is offered in person and virtually at University of Colorado, Cancer Center and Center for Rare Melanoma for…
08/31/2022

University of Michigan Health | Oct. 1, 2022

…Christopher D. Lao, MD, MPH Professor of Internal Medicine and Dermatology Samantha Guild President AIM at Melanoma Foundation https://youtu.be/1p7tdr2BQIU 8:40 AM ET…
05/15/2024

DIGA Volunteer Opportunities

…with AIM at Melanoma provides your DIGA chapter an exceptional opportunity to elevate melanoma awareness and champion preventive actions. By…
Featured image for “Replimune Announces Positive Topline Primary Analysis Data by Independent Central Review from IGNYTE Clinical Trial of RP1 plus Nivolumab in Anti-PD1 Failed Melanoma”
06/06/2024

Replimune Announces Positive Topline Primary Analysis Data by Independent Central Review from IGNYTE Clinical Trial of RP1 plus Nivolumab in Anti-PD1 Failed Melanoma

Replimune Announces Positive Topline Primary Analysis Data by Independent Central Review from IGNYTE Clinical Trial of RP1 plus Nivolumab in…
Blog - Melanoma360
Breaking News
Melanoma Research
Featured image for “Long-term Results Continue to Show a Benefit with Nivolumab and Ipilimumab”
09/15/2024

Long-term Results Continue to Show a Benefit with Nivolumab and Ipilimumab

…approved for use in melanoma, no successful approach to treating advanced melanoma existed. Although chemotherapy has existed for many decades,…
Blog - Melanoma360
Melanoma Research
Featured image for “Summit of Survival: Tobi’s Journey Beyond Melanoma”
08/10/2024

Summit of Survival: Tobi’s Journey Beyond Melanoma

In this episode, we are joined by Tobi Sample, a melanoma survivor, to share an extraordinary and inspiring story. Today,…
Blog - Melanoma360
Podcast

Protecting Your Skin

…later develop into melanoma and other skin cancers. Sun protection is essential to melanoma prevention because exposure to ultraviolet (UV)…
Featured image for “Protecting Your Skin”

Mole Mapping

…history of melanoma in your family? Have you been diagnosed with melanoma? Do you have any large moles (diameter more…
Featured image for “Mole Mapping”

Terms of Use

…names, trademarks and service marks of the Foundation include without limitation, “AIM at Melanoma,” “Melanoma 360,” “International Melanoma Working Group,”…
Featured image for “Terms of Use”

Monthly Giving Program

…Melanoma Working Group, a global collaboration of 25+ of the world’s leading experts in melanoma, who are determined to advance…
Featured image for “Monthly Giving Program”

UC Cancer Center | September 24, 2022

…This presentation is offered in person and virtually at University of Colorado, Cancer Center and Center for Rare Melanoma for…
Featured image for “UC Cancer Center | September 24, 2022”

University of Michigan Health | Oct. 1, 2022

…Christopher D. Lao, MD, MPH Professor of Internal Medicine and Dermatology Samantha Guild President AIM at Melanoma Foundation https://youtu.be/1p7tdr2BQIU 8:40 AM ET…
Featured image for “University of Michigan Health | Oct. 1, 2022”

DIGA Volunteer Opportunities

…with AIM at Melanoma provides your DIGA chapter an exceptional opportunity to elevate melanoma awareness and champion preventive actions. By…
Featured image for “DIGA Volunteer Opportunities”

Replimune Announces Positive Topline Primary Analysis Data by Independent Central Review from IGNYTE Clinical Trial of RP1 plus Nivolumab in Anti-PD1 Failed Melanoma

Replimune Announces Positive Topline Primary Analysis Data by Independent Central Review from IGNYTE Clinical Trial of RP1 plus Nivolumab in…
Featured image for “Replimune Announces Positive Topline Primary Analysis Data by Independent Central Review from IGNYTE Clinical Trial of RP1 plus Nivolumab in Anti-PD1 Failed Melanoma”
Blog - Melanoma360
Breaking News
Melanoma Research

Long-term Results Continue to Show a Benefit with Nivolumab and Ipilimumab

…approved for use in melanoma, no successful approach to treating advanced melanoma existed. Although chemotherapy has existed for many decades,…
Featured image for “Long-term Results Continue to Show a Benefit with Nivolumab and Ipilimumab”
Blog - Melanoma360
Melanoma Research

Summit of Survival: Tobi’s Journey Beyond Melanoma

In this episode, we are joined by Tobi Sample, a melanoma survivor, to share an extraordinary and inspiring story. Today,…
Featured image for “Summit of Survival: Tobi’s Journey Beyond Melanoma”
Blog - Melanoma360
Podcast